GET DAILY SIGNALSAMN Healthcare Services (AMN) Delivers Strong Q3 Beat with Revenue +13% Above Estimates
Key Takeaways
- AMN Healthcare Services reported third quarter 2026 revenue of $717.3 million, up 13% year over year and well above the roughly $649 million consensus estimate.
- Adjusted earnings per share (EPS) came in at $1.16, far exceeding the analyst consensus of $0.23, while GAAP (Generally Accepted Accounting Principles) net income reached $0.83 per share.
- Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) was $94 million, or 13% of revenue, helped by a jump in labor disruption revenue.
- Management guided fourth quarter 2026 revenue to $655 million to $670 million, modestly above the consensus of about $653.8 million.
- Gross margin of 31.9% landed 440 basis points above the top end of guidance, reflecting favorable reserve adjustments tied to prior labor disruption events.
Earnings Context and Why It Matters
AMN Healthcare Services stands as one of the largest healthcare workforce and staffing providers in the United States, linking hospitals and clinics with travel nurses, allied professionals, physicians, and technology solutions. Its quarterly results act as a useful indicator for healthcare labor demand, which has shown volatility since the pandemic-driven staffing surge eased. After several quarters of normalization, I have been watching closely for signs of a sustained rebound in travel nurse and allied volumes. A sharp third-quarter beat driven partly by labor disruption reserve adjustments—rather than purely organic demand—raises important questions about the sustainability of margins, making this report a key reference point for gauging the company's earnings trajectory heading into 2027. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Reported Results
For the third quarter of 2026, AMN Healthcare Services reported revenue of $717.3 million, a 13% increase from the prior-year period and roughly $68 million above the consensus estimate of about $648.9 million. Adjusted EPS was $1.16, compared with analyst expectations of $0.23, while GAAP net income was $0.83 per share. Net income totaled $33 million, up from $29 million a year earlier.
The revenue upside was driven by strong performance in travel nurse and allied staffing, along with $59 million of labor disruption revenue versus the $7 million the company had assumed in its guidance. The additional revenue consisted largely of reserve adjustments tied to prior labor disruption events. These adjustments lifted reported gross margin to 31.9%, or 440 basis points above the top end of guidance, and added roughly 520 basis points to gross margin. Adjusted EBITDA reached $94 million, or 13% of revenue.
Segment results were mixed. Nurse and Allied revenue was $460 million, with travel nurse volume up 21% year over year and allied volume up 12%. Physician and Leadership Solutions revenue fell 4% to $171 million, while Technology and Workforce Solutions revenue declined 9% to $86 million, reflecting continued pricing pressure in language services.
For the fourth quarter, the company guided revenue to a range of $655 million to $670 million, above the consensus of approximately $653.8 million, with adjusted EBITDA margin expected between 5.8% and 6.3%.
Market Reaction and Investor Sentiment
Shares of AMN Healthcare Services rose about 3% in after-hours trading following the release, reflecting investor relief that results landed well ahead of expectations. The magnitude of the beat, however, was amplified by non-recurring reserve adjustments related to prior labor disruption events, which some analysts and investors may discount when assessing underlying profitability. Sentiment entering the quarter had been cautious given ongoing pricing pressure in language services and the vendor management system (VMS) business. The after-market gain suggests the market focused on the top- and bottom-line upside, though the sustainability of margins excluding these adjustments remains a central question for the stock's longer-term direction. From what I see, this reaction highlights how investors are weighing the one-time factors carefully.
Forward Outlook and Key Factors to Monitor
Investors will now shift attention to whether AMN Healthcare Services can convert its third-quarter momentum into consistent organic growth. Management's fourth-quarter revenue guidance of $655 million to $670 million implies a sequential step down from the $717.3 million reported in the third quarter, as the elevated labor disruption revenue is not expected to repeat. This makes the underlying demand trends in travel nurse and allied staffing the most important variable to track.
Another key factor is international nurse volume. The company reported 32% year-over-year growth in the segment during the third quarter but expects volumes to decline sequentially beginning in the fourth quarter until embassy visa appointments normalize. This adds a degree of uncertainty to near-term results.
Margin durability will also be in focus. Excluding the labor disruption reserve adjustments, gross margin would have been considerably lower, so investors should monitor whether travel nurse bill rates and allied pricing can stabilize. Finally, the Technology and Workforce Solutions segment continues to face pricing pressure in language services, and management has signaled potential gross margin benefits from its global workforce strategy in the first half of next year. How these initiatives progress will help determine the path of profitability into 2027. One thing that stands out here is the need to separate recurring trends from temporary boosts.
Using AI Tools for Deeper Analysis
In my research on AMN Healthcare Services, I turned to Tickeron’s AI-powered tools to cross-check patterns and compare performance across the healthcare staffing sector. These resources help refine how I evaluate earnings beats and forward guidance in a data-driven way.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Aroon Indicator for AMN shows an upward move is likely
AMN's Aroon Indicator triggered a bullish signal on November 04, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 164 similar instances where the Aroon Indicator showed a similar pattern. In 135 of the 164 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +0.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMN advanced for three days, in 222 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 53 of 65 cases where AMN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
AMN broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AMN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.494) is normal, around the industry mean (204.059). P/E Ratio (17.551) is within average values for comparable stocks, (18.581). Projected Growth (PEG Ratio) (1.159) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.091) among similar stocks. P/S Ratio (0.397) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of healthcare staffing and workforce services
Industry HospitalNursingManagement
Advertisement